Sites that lack the proper skills and staff can delay the delivery of drugs to the market. But did you know that artificial intelligence can tap into data to create intelligent site profiles? Discover how site validation can be improved by combining qualitative and quantitative data.
Determining a site's feasibility for clinical research is a critical component of the entire trial process that can easily become disjointed, involving multiple disparate systems and rounds of data gathering. Learn how automation and standardization can improve the site-sponsor journey.
Cognizant's Kavitha Lokesh, vice president of life sciences products, and Vishal Janani, director of product management, life sciences, share their recommendations on how pharma companies, sites, and technology providers can ensure that the whole ecosystem works in unison.
Uncover how an industry pioneer and veteran biotech benefited from Cognizant SIP, including streamlined feasibility questionnaires where principal investigators could spend more time addressing critical, study-specific topics and reduced overall completion time by 36%.
Industry experts share their perspectives on the process and building blocks of end-to-end clinical development, the essential elements of a unified clinical platform, and the benefits and challenges involved in realizing the vision of a unified clinical platform.
Cognizant SIP helps reduce many of the redundant tasks associated with site selection and qualification. Witness how the platform is enabling teams to work with sponsors in a central workspace.
